[1]庄炜,李莉,湛韬,等.康艾注射液联合TP化疗方案治疗非小细胞肺癌的Meta分析[J].中国中医药信息杂志,2011,18(5):29-32.[doi:10.3969/j.issn.1005-5304.2011.05.011]
 ZHUANG Wei,LI Li,ZHAN Tao,et al.Meta-analysis of Kang Ai Injection Together with TP Model Chemotherapy for Treatment of Non-small Cell Lung Cancer[J].zhongguo zhongyiyao xinxi zazhi,2011,18(5):29-32.[doi:10.3969/j.issn.1005-5304.2011.05.011]
点击复制

康艾注射液联合TP化疗方案治疗非小细胞肺癌的Meta分析

参考文献/References:

[1] Pirker R, Periera JR, Szczesna A, et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX):an open label randomized phase Ⅲ trial[J]. Lancet, 2009,373:1525-1531.

[2] Chang A. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC[J]. Lung Cancer,2011,71(1):3-10.

[3] Jadad AR, Cook DJ, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses:a comparison of Cochrane reviews with articles published in paper-based journals[J]. JAMA,1998,280(3):278-280.

[4] Aldeson P, Green S, Higgins JPT. Cochrane Reviews’ Handbook 4.2.3 [Updated December 2004] [M/CD]//The Cochrane Library, Issue 1. Chichester,UK:John Wiley & Sons, Ltd.,2005.

[5] 王柳飞,王勇.TP方案化疗联合康艾注射液治疗中晚期非小细胞肺癌疗效观察[J].中国社区医师,2010,12(14):64-65.

[6] 张锦林,杨磊.康艾注射液联合TP 方案治疗中晚期肺癌的临床观察[J].现代肿瘤医学,2010,18(6):1132-1134.

[7] 李进章,姬发祥,赵久达,等.康艾注射液联合化疗治疗晚期非小细胞肺癌临床研究[J].中国现代医药杂志,2009,11(12):12-13.

[8] 张明娟,左彩凤,柴林强.康艾注射液联合化疗治疗中、晚期非小细胞肺癌的临床观察[J].上海医药,2009,30(5):213-215.

[9] 吴丹红,陈乃杰,陈云莺,等.康艾注射液配合紫杉醇加DDP 化疗治疗晚期非小细胞肺癌28例[J].福建中医药,2009,40(5):20-21.

[10] 沈存芳.中药康艾注射液加TP方案化疗治疗晚期非小细胞肺癌30例[J].第四军医大学学报,2009,30(12):1063.

[11] 严文辉,彭新茂,朱中山,等.康艾注射液联合DP方案治疗晚期非小细胞肺癌对照研究[J].中南药学,2009,7(5):384-386.

[12] 姚志华,张明智.中药抗恶性肿瘤研究进展[J].现代肿瘤医学,2006, 14(4):503-505.

相似文献/References:

[1]袁小龙,李婷,王勤.基于文献的康艾注射液不良反应分析[J].中国中医药信息杂志,2012,19(12):20.[doi:10.3969/j.issn.1005-5304.2012.12.008]
 YUAN Xiao-long,LI Ting,WANG Qin.Adverse Drug Reactions of Kang’ai Injection Based on Literature[J].zhongguo zhongyiyao xinxi zazhi,2012,19(5):20.[doi:10.3969/j.issn.1005-5304.2012.12.008]

更新日期/Last Update: